false 0001811109 0001811109 2024-05-14 2024-05-14 0001811109 AUVI:CommonStockParValue0.0001PerShareMember 2024-05-14 2024-05-14 0001811109 AUVI:Sec10.5SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember 2024-05-14 2024-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 14, 2024

 

APPLIED UV, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-39480   84-4373308
(State or other jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification Number)

 

150 N. Macquesten Parkway

Mount Vernon, NY

   10550
(Address of registrant’s principal executive office)   (Zip code)

 

(914) 665-6100

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   AUVI   The Nasdaq Stock Market LLC
10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share     AUVIP     The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On May 15, 2024, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 15, 2024, indicating that, as a result of Eugene Burleson’s resignation from the Board of Directors of the Company (“Board”), the audit committee of the Board (the “Audit Committee”), effective May 7, 2024, the Company is not currently in compliance with Nasdaq Listing Rule 5605, which requires that the Audit Committee is comprised of at least three independent directors.

 

The Audit Committee currently is comprised of only two independent directors, Joseph Luhukay and Christopher Kochuba. In accordance with Nasdaq Listing Rule 5605(b)(1)(A), the Company has a “cure period” of until the earlier of the Company’s next annual shareholders’ meeting or May 7, 2025, or if the next annual shareholders’ meeting is held before November 4, 2024, then the Company must evidence compliance no later than November 4, 2024. The Company intends to elect one independent director to serve as a member of the Audit Committee during this cure period.

 

The Notice has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Capital Market.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On May 14, 2024, the Board of Directors (“Board”) of Applied UV, Inc. appointed Christopher Kochuba as a member of the Audit Committee and compensation committee of the Board effective as of May 14, 2024.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 APPLIED UV, INC.
   
Date: May 17, 2024 By: /s/ Mike Riccio
  Name:  Mike Riccio
  Title: Chief Financial Officer

 

 

2

 

 

v3.24.1.1.u2
Cover
May 14, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date May 14, 2024
Entity File Number 001-39480
Entity Registrant Name APPLIED UV, INC.
Entity Central Index Key 0001811109
Entity Tax Identification Number 84-4373308
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 150 N. Macquesten Parkway
Entity Address, City or Town Mount Vernon
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10550
City Area Code 914
Local Phone Number 665-6100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, par value $0.0001 per share  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol AUVI
Security Exchange Name NASDAQ
10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share    
Title of 12(b) Security 10.5% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share  
Trading Symbol AUVIP  
Security Exchange Name NASDAQ
Applied UV (NASDAQ:AUVIP)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Applied UV Charts.
Applied UV (NASDAQ:AUVIP)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Applied UV Charts.